SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-018458
Filing Date
2024-05-09
Accepted
2024-05-09 16:27:31
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 903908
2 ex31-1.htm EX-31.1 18011
3 ex31-2.htm EX-31.2 18273
4 ex32-1.htm EX-32.1 7314
5 ex32-2.htm EX-32.2 7329
6 form10-q_001.jpg GRAPHIC 31301
7 form10-q_002.jpg GRAPHIC 23289
  Complete submission text file 0001493152-24-018458.txt   5414674

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE immx-20240331.xsd EX-101.SCH 41681
9 XBRL CALCULATION FILE immx-20240331_cal.xml EX-101.CAL 53421
10 XBRL DEFINITION FILE immx-20240331_def.xml EX-101.DEF 175329
11 XBRL LABEL FILE immx-20240331_lab.xml EX-101.LAB 367802
12 XBRL PRESENTATION FILE immx-20240331_pre.xml EX-101.PRE 278131
66 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 761435
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

IRS No.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41159 | Film No.: 24931161
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)